2月19日 - ** 减肥生物技术公司Allurion Technologies ALUR.N股价下跌32.2%，至3.78美元
** ALUR称 (link)，该公司将通过股票发行和私募融资约610万美元。
** 公司将以每股5.23美元的价格出售900,000股普通股，并发行认股权证，最多可购买180万股。
** 发行价比股票最后收盘价折价 6.3
** 资金将用于推进公司的临床项目，包括测试 Allurion Balloon 和 GLP-1 疗法 - ALUR 的效果。
** Roth Capital Partners 是此次发行和私募的独家配售代理
** 根据 LSEG 的数据，公司有 480 万股流通股，市值为 2680 万美元。
** 2024 年股价下跌 87.8%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.